It is currently unknown whether the REST-HAR1 axis is functionally relevant for glioma pathogenesis, or whether REST exerts its oncogenic function in a HAR-independent manner (e.g., primarily via the repression of protein-coding genes). The gene discussed is REST; the disease is central nervous system cancer.